Spondylolysis: Clinical Trials

3 trials for Spondylolysis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 23Completed 3

Follow Spondylolysis: new trials by email Literature Review of Spondylolysis trials Research Report on Spondylolysis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Preliminary Effectiveness of NVD-001 for the Treatment of Low Grade Degenerative Lumbar Spondylolisthesis
NVD-001, Standard of Care - Spondylolisthesis
Phase 1 / Phase 2CompletedNovadip Biosciences482017-01-012021-08-13
Safety Study of Mesenchymal Stem Cells and Spinal Fusion
XCEL-MT-OSTEO-ALPHA, Standard treatment - Lumbar Spondylolisthesis Involving L4-L5, and/or, Degenerative Discopathy Involving L4-L5
Phase 1 / Phase 2CompletedBanc de Sang i Teixits692012-07-192020-01-21
Study of 3 Doses of NeoFuse Combined With MasterGraft Granules in Subjects Requiring Posterolateral Lumbar Fusion (PLF)
NeoFuse, posterolateral spinal fusion with instrumentation - Degenerative Disc Disease, Spondylolisthesis
Phase 1 / Phase 2CompletedMesoblast, Ltd.62007-10-012020-06-29

Narrower conditions

Spondylolisthesis (3)  ·  Intervertebral Disc Degeneration (1)  ·  Spinal Stenosis (1)

Broader conditions

Bone Diseases (3)  ·  Musculoskeletal Diseases (3)  ·  Spinal Diseases (3)  ·  Spondylosis (3)

Interventions

Spinal Fusion (1)  ·  Standard of Care (1)

Sponsors

Banc de Sang i Teixits (1)  ·  Mesoblast, Ltd. (1)  ·  Novadip Biosciences (1)

Countries

Belgium (1)  ·  Czechia (1)  ·  Poland (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Christian Raftopoulos, MD, PhD (1)  ·  Denis Dufrane, MD, PhD (1)  ·  Donna Skerrett, MD (1)

Results publications

PMID 25769789

NIH funding

2016 (1)